3.4.22.B30: calpain 10
This is an abbreviated version!
For detailed information about calpain 10, go to the full flat file.
Word Map on EC 3.4.22.B30
-
3.4.22.B30
-
calpains
-
mellitus
-
ucsnp-43
-
polycystic
-
tcf7l2
-
mexican
-
kcnj11
-
medicine
-
mexican-american
-
pro12ala
-
7-like
-
igf2bp2
-
haplogenotype
-
cdkal1
-
drug development
- 3.4.22.B30
- calpains
- mellitus
-
ucsnp-43
-
polycystic
-
tcf7l2
-
mexican
-
kcnj11
- medicine
-
mexican-american
-
pro12ala
-
7-like
-
igf2bp2
-
haplogenotype
- cdkal1
- drug development
Reaction
broad endopeptidase specificity =
Synonyms
calpain 10, calpain-10, CAPN10
ECTree
Advanced search results
Expression
Expression on EC 3.4.22.B30 - calpain 10
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
calpain-10 expression is elevated by 64% in pancreatic islets from patients with type 2 diabetes compared with non-diabetic donors
-
calpain-10 is overexpressed and activated through the inhibition of ryanodine receptor 2 under hypoglycemic and high fatty acid conditions, causing caspase-3-independent beta-cell death
chronic high glucose down-regulates mitochondrial calpain 10. High glucose (17 mM) decreases mitochondrial calpain 10 mRNA and protein at 96 h compared with cells incubated with 0 or 5 mM glucose or 17 mM D-mannitol. Renal calpain 10 protein and mRNA are specifically decreased in streptozotocin-induced diabetic rats with kidney dysfunction
-
mitochondrial calpain activity does not change with 5mM glucose or 17 mM D-mannitol
-
renal calpain 10 protein and mRNA are specifically decreased in ob/ob diabetic mice
-